Odd T. Brustugun

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Journal: Molecular cancer

Published: February 27, 2026

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 19, 2026

Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

Journal: FEBS open bio

Published: January 16, 2026

CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancer.

CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancer.

Journal: Frontiers in oncology

Published: November 27, 2025

Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).

Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 10, 2025

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

Journal: NPJ precision oncology

Published: October 29, 2025

Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway.

Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway.

Journal: BJC reports

Published: May 20, 2025

Acquired angioedema and rituximab-induced acute thrombocytopenia in splenic marginal zone lymphoma.

Acquired angioedema and rituximab-induced acute thrombocytopenia in splenic marginal zone lymphoma.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 19, 2025

Lung Cancer in Norway.

Lung Cancer in Norway.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 26, 2025

Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study.

Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study.

Journal: Frontiers in oncology

Published: March 17, 2025

High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.

High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 14, 2025

Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance.

Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance.

Journal: Journal of extracellular vesicles

Published: October 21, 2024

Showing 1-12 of 130

Last Updated: 09/26/2026